Near‐normoglycaemic remission in African‐Americans with Type 2 diabetes mellitus is associated with recovery of beta cell function
The DOI matches its Crossref record; 6 of the 6 references it cites were found in a registry or an index.
Abstract
SUMMARY Aims To prospectively determine the frequency of remission and possible mechanism of beta cell recovery in non‐Whites with Type 2 diabetes mellitus in the setting of intensive glycaemic regulation using pharmacological agents. Methods Twenty‐six consecutive, newly diagnosed African‐American, Type 2 diabetic patients presenting primarily for severe hyperglycaemia (31.0 ± 12.8 mmol/l) were followed for at least 1 year. Initial hospitalization included treatment with insulin, fluids and electrolytes. Outpatient intensive glycaemic regulation included insulin or glibenclamide, diabetes education and diet that altered nutrient content. Plasma glucose and C‐peptide responses to an oral glucose tolerance test and HbA 1c were measured at < 14, 15–56 and 57–112 days after presentation. Remission was defined as a HbA 1c ≤ 6.3% and fasting plasma glucose < 6.9 mmol/l, 3 months after discontinuing all pharmacological agents. Results Eleven of 26 patients (42.3%) developed remission after a mean of 83 days of pharmacological treatment and remained in remission during follow‐up for 248–479 days; one relapsed after 294 days. Fifteen patients who did not develop a remission and were followed for 168–468 days, required continuing pharmacological therapy to be well‐controlled. (mean HbA 1c = 7.1%). There was no significant difference in age, sex, plasma glucose at presentation, initial glycaemic regulation, final body mass index, magnitude of weight change or pharmacological agents used for treatment between the two groups. Plasma C‐peptide response to oral glucose was initially (< 14 days) suppressed in all subjects and subsequently increased. The increase was significantly greater in those who underwent a remission than those who did not. Neither significant weight loss nor severe hypoglycaemia was observed in either group during intensive treatment. Conclusions Forty‐two per cent of newly diagnosed, unselected African‐Americans with Type 2 diabetes, treated intensively using pharmacological agents, education and diet developed near‐normoglycaemic remission. Remission was associated with a greater recovery of glucose‐stimulated insulin secretion suggesting that therapies directed at promoting beta cell recovery and preservation are potentially useful approaches to the treatment of Type 2 diabetes mellitus.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
U.K. Prospective Diabetes Study Group (1995) · Diabetes · doi:10.2337/diab.44.11.1249 · Cited by 1,923
(2000) · New England Journal of Medicine · doi:10.1056/nejm200002103420603 · Cited by 1,534
Donath, M. Y., Gross, D. J., Cerasi, E., & Kaiser, N. (1999) · Diabetes · doi:10.2337/diabetes.48.4.738 · Cited by 405
Ilkova, H., Glaser, B., Tunçkale, A., Bagriaçik, N., & Cerasi, E. (1997) · Diabetes Care · doi:10.2337/diacare.20.9.1353 · Cited by 269
Banerji, M. A., Chaiken, R. L., Huey, H., Tuomi, T., Norin, A. J., Mackay, I. R., Rowley, M. J., Zimmet, P. Z., & Lebovitz, H. E. (1994) · Diabetes · doi:10.2337/diab.43.6.741 · Cited by 266
Self-citation
Cited by
Weng, J., Li, Y., Xu, W., Shi, L., Zhang, Q., Zhu, D., Hu, Y., Zhou, Z., Yan, X., Tian, H., et al. (2008) · The Lancet · doi:10.1016/s0140-6736(08)60762-x · Cited by 780
Diabetes in sub-Saharan Africa
Mbanya, J. C. N., Motala, A. A., Sobngwi, E., Assah, F. K., & Enoru, S. T. (2010) · The Lancet · doi:10.1016/s0140-6736(10)60550-8 · Cited by 775
Li, Y., Xu, W., Liao, Z., Yao, B., Chen, X., Huang, Z., Hu, G., & Weng, J. (2004) · Diabetes Care · doi:10.2337/diacare.27.11.2597 · Cited by 323
Ketosis-Prone Type 2 Diabetes in Patients of Sub-Saharan African Origin
Mauvais-Jarvis, F., Sobngwi, E., Porcher, R., Riveline, J.-P., Kevorkian, J.-P., Vaisse, C., Charpentier, G., Guillausseau, P.-J., Vexiau, P., & Gautier, J.-F. (2004) · Diabetes · doi:10.2337/diabetes.53.3.645 · Cited by 294
“This pattern of acute and reversible insulin deficiency has already been described by other investigators (6,25).”
BackgroundNarrative Review: Ketosis-Prone Type 2 Diabetes Mellitus
Umpierrez, G. E., Smiley, D., & Kitabchi, A. E. (2006) · Annals of Internal Medicine · doi:10.7326/0003-4819-144-5-200603070-00011 · Cited by 299
“The mean body mass index at presentation in African-American patients with ketosis-prone type 2 diabetes has ranged between 28 kg/m(2) to 37 kg/m(2) (2, 5, 6, 25).”
Background
Metadata
- Authors
- McFarlane, S. I., Chaiken, R. L., Hirsch, S., Harrington, P., Lebovitz, H. E., & Banerji, M. A.
- Venue
- Diabetic Medicine
- Publisher
- Wiley
- Published
- 2001-01
- Volume
- 18
- Issue
- 1
- Pages
- 10-16
- ISSN
- 0742-3071 (ISSN-L)
- 1464-5491
- OpenAlex
- W2146975696
- Cited by
- 111
- References
- 6
- FWCI
- 3.32
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Near‐normoglycaemic remission in African‐Americans with Type 2 diabetes mellitus is associated with recovery of beta cell function. https://app.cochat.ai/papers/10.1046/j.1464-5491.2001.00395.x
- The paper
- McFarlane, S. I., Chaiken, R. L., Hirsch, S., Harrington, P., Lebovitz, H. E., & Banerji, M. A. (2001). Near‐normoglycaemic remission in African‐Americans with Type 2 diabetes mellitus is associated with recovery of beta cell function. Diabetic Medicine. https://doi.org/10.1046/j.1464-5491.2001.00395.x
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.